¼¼°èÀÇ ¼Õ¹ß¹Ù´Ú ³óÆ÷Áõ ½ÃÀå º¸°í¼­(2025³â)
Palmoplantar Pustulosis Global Market Report 2025
»óǰÄÚµå : 1730982
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¼Õ¹ß¹Ù´Ú ³óÆ÷Áõ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÇǺΰúÇÐ ¿¬±¸ÀÇ ¹ßÀü, »ý¹°ÇÐÀû Á¦Á¦¿Í ¸é¿ªÁ¶ÀýÁ¦·ÎÀÇ Àüȯ, ÇǺΰú Áø´Ü¿¡ À־ÀÇ ÀΰøÁö´ÉÀÇ ÅëÇÕ, °íµµÀÇ ±¹¼Ò Á¦Á¦ÀÇ °³¹ß, ÇǺΰúÇÐ ¿¬±¸¿¡ À־ÀÇ ¸Ó½Å·¯´×ÀÇ ÀÌ¿ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

ÇǺΠÁúȯÀÇ À¯º´·üÀÇ »ó½ÂÀº Àå¹ß ³óÆ÷Áõ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ´ë±â ¿À¿°, ÀÌ»ó ±â»ó, À¯ÇØÇÑ È­ÇÐ ¹°Áú¿¡ ³ëÃâ µîÀÇ È¯°æÀÇ ¿µÇâÀº ÇǺθ¦ ÀÚ±ØÇÏ°í ½ÀÁøÀ̳ª ¿©µå¸§ µîÀÇ Áõ»óÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ÀÌ Áõ»óÀº ÇǺΠ°Ç°­À» °³¼±ÇÏ°í ºÒÄè°¨À» ¿ÏÈ­ÇϱâÀ§ÇÑ ´Ù¾çÇÑ Ä¡·á·Î °ü¸® ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼Õ¹ß¹Ù´Ú ³óÆ÷Áõ ½ÃÀåÀÇ °¢»ç´Â ¿°Áõ°æ·Î¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ´ÜÀÏŬ·ÐÇ×ü µîÀÇ Çõ½ÅÀûÀÎ Ä¡·á¹ýÀ» °³¹ßÇÏ¿© ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. 2023³â 8¿ù, ÀϺ»ÀÇ Á¦¾àȸ»çÀÎ Kyowa Kirin Co., Ltd.´Â LUMICEFÀÇ ¼Õ¹ß¹Ù´Ú ³óÆ÷Áõ Ä¡·á¿¡ ´ëÇÑ ÀϺΠ½ÂÀÎÀ» ÀϺ»¿¡¼­ ÃëµæÇß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - °Å½Ã°æÁ¦ ½Ã³ª¸®¿À ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÇü Äڷγª ¹ÙÀÌ·¯½º °¨¿°ÀÇ ¿µÇâ°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Palmoplantar pustulosis is a chronic skin disorder characterized by the development of pustules (small, pus-filled blisters) on the palms of the hands and soles of the feet. This condition often leads to redness, scaling, and thickening of the skin in these areas. It can be painful and is commonly associated with other skin conditions, such as psoriasis.

The primary treatment options for palmoplantar pustulosis include topical treatments, systemic therapies, biologics, and phototherapy. Topical treatments aim to reduce inflammation, manage symptoms, and prevent flare-ups, and may involve corticosteroids, vitamin D analogs, calcineurin inhibitors, keratolytics, or coal tar. These treatments are used in various healthcare settings, such as hospitals, dermatology clinics, and home care environments, and are distributed through multiple channels, including online pharmacies, retail pharmacies, and hospitals.

The palmoplantar pustulosis market research report is one of a series of new reports from The Business Research Company that provides palmoplantar pustulosis market statistics, including the palmoplantar pustulosis industry global market size, regional shares, competitors with the palmoplantar pustulosis market share, detailed palmoplantar pustulosis market segments, market trends, and opportunities, and any further data you may need to thrive in the palmoplantar pustulosis industry. This palmoplantar pustulosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The palmoplantar pustulosis market size has grown strongly in recent years. It will grow from $1.93 billion in 2024 to $2.10 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth observed during the historical period can be attributed to factors such as the increasing prevalence of autoimmune disorders, greater awareness of rare skin diseases, higher healthcare spending, and the growing adoption of telemedicine in dermatology.

The palmoplantar pustulosis market size is expected to see strong growth in the next few years. It will grow to $2.84 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period is expected to be driven by the rising adoption of biologic therapies, increased investments in dermatology research, a growing pipeline of novel treatments, rising demand for personalized medicine, and the increasing prevalence of chronic skin conditions. Key trends for the forecast period include advancements in dermatology research, a shift toward biologics and immunomodulators, the integration of artificial intelligence in dermatological diagnosis, the development of advanced topical formulations, and the use of machine learning in dermatological research.

The rising prevalence of skin disorders is expected to drive the growth of the palmoplantar pustulosis market. Skin disorders are conditions that impact the skin's structure, function, or appearance, and their increasing incidence is attributed to environmental changes, lifestyle habits, and genetic factors. Environmental influences, such as air pollution, extreme weather conditions, and exposure to harmful chemicals, can irritate the skin and trigger conditions such as eczema or acne. Palmoplantar pustulosis is a chronic skin disorder that primarily affects the palms of the hands and soles of the feet, causing pustules, redness, and scaling. This condition can be managed with various treatments to improve skin health and reduce discomfort. For example, in 2022, the International Eczema Council reported that approximately 223 million people worldwide were affected by atopic dermatitis, with 43 million of them aged between 1 and 4 years old. As skin disorders become more prevalent, the growth of the palmoplantar pustulosis market is accelerating.

Companies in the palmoplantar pustulosis market are developing innovative treatments, such as monoclonal antibodies targeting inflammatory pathways, to improve patient outcomes. Monoclonal antibodies (mAbs) are identical antibodies produced by a single B cell clone and are designed to target specific antigens for therapeutic or diagnostic purposes. For example, in August 2023, Kyowa Kirin Co., Ltd., a Japan-based pharmaceutical company, received partial approval for LUMICEF for palmoplantar pustulosis treatment in Japan. LUMICEF is a targeted therapy that blocks IL-17, providing rapid and lasting relief for inflammatory conditions such as psoriasis and palmoplantar pustulosis. Its goal is to reduce inflammation and enhance the quality of life for patients with chronic skin diseases.

In October 2024, Organon & Co., a U.S.-based pharmaceutical company, acquired Dermavant Sciences Ltd. for an undisclosed sum. This acquisition allows Organon to strengthen its dermatology portfolio and improve women's health by offering innovative treatments for chronic skin conditions. Dermavant Sciences, based in the U.S., is focused on developing novel therapies for immuno-dermatological conditions, particularly targeting unmet needs in diseases such as plaque psoriasis and atopic dermatitis.

Major players in the palmoplantar pustulosis market are Pfizer Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis International AG, GlaxoSmithKline PLC (GSK), Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Bausch Health Companies Inc., Chugai Pharmaceutical Co. Ltd., Janssen Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Swedish Orphan Biovitrum AB (Sobi), Almirall S.A., MorphoSys AG, MoonLake Immunotherapeutics AG, Aristea Therapeutics Inc., AnaptysBio Inc., Taiho Pharmaceutical Co. Ltd., Kamari Pharma Ltd.

North America was the largest region in the palmoplantar pustulosis market in 2024. The regions covered in palmoplantar pustulosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the palmoplantar pustulosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The palmoplantar pustulosis market consists of revenues earned by entities by providing services such as personalized skincare and counseling, phototherapy services, pharmacological treatment services, and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The palmoplantar pustulosis market also includes sales of phototherapy devices, oral systemic therapies, medicated skincare products, topical corticosteroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Palmoplantar Pustulosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on palmoplantar pustulosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for palmoplantar pustulosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The palmoplantar pustulosis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Palmoplantar Pustulosis Market Characteristics

3. Palmoplantar Pustulosis Market Trends And Strategies

4. Palmoplantar Pustulosis Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Palmoplantar Pustulosis Growth Analysis And Strategic Analysis Framework

6. Palmoplantar Pustulosis Market Segmentation

7. Palmoplantar Pustulosis Market Regional And Country Analysis

8. Asia-Pacific Palmoplantar Pustulosis Market

9. China Palmoplantar Pustulosis Market

10. India Palmoplantar Pustulosis Market

11. Japan Palmoplantar Pustulosis Market

12. Australia Palmoplantar Pustulosis Market

13. Indonesia Palmoplantar Pustulosis Market

14. South Korea Palmoplantar Pustulosis Market

15. Western Europe Palmoplantar Pustulosis Market

16. UK Palmoplantar Pustulosis Market

17. Germany Palmoplantar Pustulosis Market

18. France Palmoplantar Pustulosis Market

19. Italy Palmoplantar Pustulosis Market

20. Spain Palmoplantar Pustulosis Market

21. Eastern Europe Palmoplantar Pustulosis Market

22. Russia Palmoplantar Pustulosis Market

23. North America Palmoplantar Pustulosis Market

24. USA Palmoplantar Pustulosis Market

25. Canada Palmoplantar Pustulosis Market

26. South America Palmoplantar Pustulosis Market

27. Brazil Palmoplantar Pustulosis Market

28. Middle East Palmoplantar Pustulosis Market

29. Africa Palmoplantar Pustulosis Market

30. Palmoplantar Pustulosis Market Competitive Landscape And Company Profiles

31. Palmoplantar Pustulosis Market Other Major And Innovative Companies

32. Global Palmoplantar Pustulosis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Palmoplantar Pustulosis Market

34. Recent Developments In The Palmoplantar Pustulosis Market

35. Palmoplantar Pustulosis Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â